ALZHEIMER'S DISEASE SIGNATURE MARKERS AND METHODS OF USE
    64.
    发明申请
    ALZHEIMER'S DISEASE SIGNATURE MARKERS AND METHODS OF USE 审中-公开
    阿尔茨海默病的标志和使用方法

    公开(公告)号:WO2013066764A2

    公开(公告)日:2013-05-10

    申请号:PCT/US2012/062218

    申请日:2012-10-26

    CPC classification number: C12Q1/6883 A01K67/0275 C12Q2600/158 G01N33/6896

    Abstract: Methods, biomarkers, and expression signatures are disclosed for assessing the disease progression of Alzheimer's disease (AD). In one embodiment, BioAge (biological age), NdStress (neurodegenerative stress), Alz (Alzheimer), and Inflame (inflammation) are used as biomarkers of AD progression. In another aspect, the invention comprises a gene signature for evaluating disease progression. In still another embodiment, methods for evaluating disease progression are provided. In yet another embodiment, the invention can be used to identify animal models for use in the development and evaluation of therapeutics for the treatment of AD.

    Abstract translation: 公开了评估阿尔茨海默氏病(AD)疾病进展的方法,生物标志物和表达特征。 在一个实施方案中,使用BioAge(生物学年龄),NdStress(神经变性应激),Alz(阿尔茨海默)和Inflame(炎症))作为AD进展的生物标志物。 另一方面,本发明包括用于评估疾病进展的基因特征。 在另一个实施方案中,提供了评估疾病进展的方法。 在另一个实施方案中,本发明可用于鉴定用于开发和评估治疗AD的动物模型。

Patent Agency Ranking